GMED
GLOBUS MEDICAL INC
$80.00
0.00%
$10.9B
No data for this timeframe.
Vol
Market Cap$10.9B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (71%)
Inst. Holders7 funds
Inst. Value$1.3B
Inst. Activity1 buys / 1 sells
Insider Activity0B / 1S
Insider Net $-$876.7K
SEC Reports4
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001237831·Prev Close $80.00
Recent Activity
Jun 5, 2026
SEC
Globus Medical filed an 8-K reporting that stockholders approved an amendment to the 2021 Equity Incentive Plan, increas
8-K — Impact 3/10
Jun 4, 2026
SEC
The Federal Circuit reversed the PTAB's Final Written Decision, adopting Life Spine's broader construction of the claim
COURT-RULING — Impact 7/10
Apr 24, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Feb 25, 2026
Insider
Huller Kelly sold 20,000 shares
EVP, GC, Corporate Secretary @ $43.58 ($871.6K)
Feb 25, 2026
Insider
Huller Kelly sold 20,000 shares
EVP, GC, Corporate Secretary @ $0.00 ($0.00)
Feb 12, 2026
Insider
Huller Kelly sold 10,000 shares
EVP, GC, Corporate Secretary @ $45.64 ($456.4K)
Inst.
NORGES BANK — NEW
1,029,913 shares ($89.9M)
Inst.
RENAISSANCE TECHNOLOGIES LLC — EXIT
0 shares ($0.00)
Price Targets
$110.00
+37.5% upside
Strong Buy
Current $80.00
Low $87.00
Median $115.00
High $122.00
11 analysts
$87.00
$122.00
Analyst Ratings
4Strong Buy
11Buy
6Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 8, 2026 | RBC Capital | MAINTAIN | Outperform → Outperform |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| May 8, 2026 | Needham | MAINTAIN | Buy → Buy |
| Feb 26, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| Feb 25, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.10 ▲ +3.6% | $1.05 — $1.14 | 28% YoY | 13 |
| Next Q | $1.17 | $1.11 — $1.22 | -1% YoY | 13 |
| Current FY | $4.74 ▲ +6.1% | $4.70 — $4.78 | 19% YoY | 13 |
| Next FY | $5.15 ▲ +4.1% | $4.93 — $5.30 | 9% YoY | 13 |
Latest Reports
NEUTRAL
8-K
3/10
Globus Medical filed an 8-K reporting that stockholders approved an amendment to the 2021 Equity Incentive Plan, increas
Jun 5, 2026
BEARISH
COURT-RULING
7/10
The Federal Circuit reversed the PTAB's Final Written Decision, adopting Life Spine's broader construction of the claim
Jun 4, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $921.1M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $104.0M | NEW |
| NORGES BANK | $89.9M | NEW |
| MORGAN STANLEY | $80.7M | ADD |
| BANK OF AMERICA CORP | $66.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Feb 25, 2026 | Huller Kelly | M | $871.6K |
| Feb 25, 2026 | Huller Kelly | M | $0.00 |
| Feb 12, 2026 | Huller Kelly | M | $456.4K |
| Feb 12, 2026 | Huller Kelly | SELL | $876.7K |
| Feb 12, 2026 | Huller Kelly | M | $0.00 |
7 institutional holders with $1.3B total value (14,791,989 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, NORGES.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 10,549,455 | $921.1M | 71.3% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,190,617 | $104.0M | 8.0% | NEW |
| 3 | NORGES BANK | 1,029,913 | $89.9M | 7.0% | NEW |
| 4 | MORGAN STANLEY | 924,375 | $80.7M | 6.2% | ADD +27.6% |
| 5 | BANK OF AMERICA CORP /DE/ | 758,627 | $66.2M | 5.1% | — |
| 6 | WELLS FARGO & COMPANY/MN | 289,838 | $25.3M | 2.0% | — |
| 7 | FMR LLC | 49,164 | $4.3M | 0.3% | NEAR_EXIT -93.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 1,029,913 | — | $89.9M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 243,918 | 0 | -100.0% | $0.00 | 2025-Q4 |
| UBS Group AG | ADD | 487,637 | 695,358 | +42.6% | $39.8M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 105,418 | 243,918 | +131.4% | $14.0M | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 760,382 | 48,170 | -93.7% | $2.8M | 2025-Q3 |
| NORGES BANK | EXIT | 1,152,793 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 1,152,793 | — | $68.0M | 2025-Q2 |
| MORGAN STANLEY | ADD | 683,101 | 871,611 | +27.6% | $51.4M | 2025-Q2 |
| FMR LLC | DOUBLED | 274,016 | 760,382 | +177.5% | $44.9M | 2025-Q2 |
| UBS Group AG | TRIM | 1,008,198 | 487,637 | -51.6% | $28.8M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 176,918 | 105,418 | -40.4% | $6.2M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 16,845 | 0 | -100.0% | $0.00 | 2025-Q2 |
| UBS Group AG | DOUBLED | 342,245 | 1,008,198 | +194.6% | $73.8M | 2025-Q1 |
| CITADEL ADVISORS LLC | NEAR_EXIT | 2,645,360 | 408,347 | -84.6% | $29.9M | 2025-Q1 |
| FMR LLC | TRIM | 427,284 | 274,016 | -35.9% | $20.1M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 176,918 | — | $13.0M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 29,486 | 16,845 | -42.9% | $1.2M | 2025-Q1 |
| NORGES BANK | EXIT | 1,415,813 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 1,613,724 | 2,645,360 | +63.9% | $218.8M | 2024-Q4 |
| MORGAN STANLEY | ADD | 587,487 | 746,161 | +27.0% | $61.7M | 2024-Q4 |
| UBS Group AG | ADD | 186,778 | 342,245 | +83.2% | $28.3M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 1,238,603 | — | $88.6M | 2024-Q3 |
1 unique insiders with 1 transactions. Net insider value: -$876.7K ($0.00 bought, $876.7K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | M | 20,000 | $43.58 | $871.6K |
| Feb 25, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | M | 20,000 | $0.00 | $0.00 |
| Feb 12, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | M | 10,000 | $45.64 | $456.4K |
| Feb 12, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | SELL | 10,000 | $87.67 | $876.7K |
| Feb 12, 2026 | Huller Kelly | EVP, GC, Corporate Secretary | M | 10,000 | $0.00 | $0.00 |
4 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 5.3/10.
NEUTRAL
8-K
3/10
Globus Medical filed an 8-K reporting that stockholders approved an amendment to the 2021 Equity Inc
Jun 5, 2026
BEARISH
COURT-RULING
7/10
The Federal Circuit reversed the PTAB's Final Written Decision, adopting Life Spine's broader constr
Jun 4, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 24, 2026
BULLISH
8-K, 8-K
8/10
Globus Medical reported strong fourth quarter and full-year 2025 results with worldwide net sales of
Feb 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (71% buy). Based on 21 analysts: 4 strong buy, 11 buy, 6 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$110.00 mean target
+37.5% upside
Strong Buy (1.85)
$87.00 Low
$122.00 High
| Metric | Value |
|---|---|
| Current Price | $80.00 |
| Target Low | $87.00 |
| Target Mean | $110.00 |
| Target Median | $115.00 |
| Target High | $122.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (1.85) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.10 | $1.05 | $1.14 | 27.7% | +3.6% | 12↑ 1↓ | $0.8B | 5.2% | 13 |
| Next Q 2026-09-30 |
$1.17 | $1.11 | $1.22 | -1.1% | -0.2% | 9↑ 4↓ | $0.8B | 3.6% | 13 |
| Current FY 2026-12-31 |
$4.74 | $4.70 | $4.78 | 19.2% | +6.1% | 14↑ 0↓ | $3.2B | 9.0% | 13 |
| Next FY 2027-12-31 |
$5.15 | $4.93 | $5.30 | 8.6% | +4.1% | 14↑ 0↓ | $3.4B | 6.4% | 13 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.098 | |
| 7d ago | $1.097 | +0.001 |
| 30d ago | $1.060 | +0.038 |
| 60d ago | $1.058 | +0.041 |
| 90d ago | $1.063 | +0.035 |
7 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 8, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| May 8, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 25, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | Needham | UPGRADE | Hold | Buy |
| Jan 9, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Jan 8, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Dec 17, 2025 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Dec 17, 2025 | Freedom Capital Markets | INITIATE | — | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 11 | 6 | 0 | 0 | 71% | |
| May 1, 2026 | 4 | 12 | 6 | 0 | 0 | 73% | |
| Apr 1, 2026 | 4 | 12 | 6 | 0 | 0 | 73% | |
| Mar 1, 2026 | 4 | 12 | 6 | 0 | 0 | 73% | |
| Feb 1, 2026 | 4 | 12 | 6 | 0 | 0 | 73% | |
| Jan 1, 2026 | 4 | 10 | 7 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 4, 2026
short_volume
Short Volume: GMED — 76.2% short (0.4M / 0.6M)
Short: 433,869 | Exempt: 449 | TRF Vol: 569,200 | Short Ratio: 76.2% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
Enforcement
Life Spine, Inc. v. Globus Medical, Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 24-2167
Jun 3, 2026
short_volume
Short Volume: GMED — 74.1% short (0.5M / 0.7M)
Short: 490,174 | Exempt: 0 | TRF Vol: 661,451 | Short Ratio: 74.1% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: GMED — 71.4% short (0.6M / 0.8M)
Short: 559,146 | Exempt: 400 | TRF Vol: 783,530 | Short Ratio: 71.4% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: GMED — 67.1% short (0.6M / 0.8M)
Short: 553,643 | Exempt: 272 | TRF Vol: 824,665 | Short Ratio: 67.1% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: GMED — 60.1% short (0.4M / 0.6M)
Short: 369,971 | Exempt: 88 | TRF Vol: 616,062 | Short Ratio: 60.1% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: GMED — 78.5% short (0.9M / 1.2M)
Short: 938,458 | Exempt: 378 | TRF Vol: 1,195,997 | Short Ratio: 78.5% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: GMED — 77.6% short (0.5M / 0.7M)
Short: 532,129 | Exempt: 765 | TRF Vol: 685,298 | Short Ratio: 77.6% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: GMED — 68.5% short (0.4M / 0.6M)
Short: 417,504 | Exempt: 5 | TRF Vol: 609,770 | Short Ratio: 68.5% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: GMED — 72.2% short (0.7M / 0.9M)
Short: 685,375 | Exempt: 425 | TRF Vol: 949,434 | Short Ratio: 72.2% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: GMED — 64.0% short (0.4M / 0.6M)
Short: 374,876 | Exempt: 0 | TRF Vol: 585,997 | Short Ratio: 64.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: GMED — 3.3M shares, 61,198 trades
Week starting 2026-05-11. Total ATS volume: 3,316,050 shares across 61,198 trades.
May 7, 2026
earnings
Globus Medical Reports First Quarter 2026 Results
<p align="justify">AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, t
May 7, 2026
earnings_calendar
GMED Q1 2026 Earnings Scheduled — 2026-05-07
May 4, 2026
dark_pool
Dark Pool: GMED — 4.5M shares, 68,337 trades
Week starting 2026-05-04. Total ATS volume: 4,477,226 shares across 68,337 trades.
Apr 27, 2026
dark_pool
Dark Pool: GMED — 1.3M shares, 36,343 trades
Week starting 2026-04-27. Total ATS volume: 1,309,315 shares across 36,343 trades.